No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹1,141.5Prev. Close
₹1,160.7Turnover(Lac.)
₹48.85Day's High
₹1,189.95Day's Low
₹1,135.0552 Week's High
₹1,23552 Week's Low
₹596.05Book Value
₹280.56Face Value
₹10Mkt Cap (₹ Cr.)
1,201.2P/E
24.47EPS
47.31Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 10.38 | 10.38 | 10.38 | 10.38 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 255.47 | 215.57 | 191.65 | 172.18 |
Net Worth | 265.85 | 225.95 | 202.03 | 182.56 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 261.5 | 138.68 | 165.15 | 136.82 |
yoy growth (%) | 88.56 | -16.02 | 20.7 | 43.54 |
Raw materials | -165.59 | -87.07 | -119.34 | -101.28 |
As % of sales | 63.32 | 62.78 | 72.26 | 74.02 |
Employee costs | -15.67 | -11.68 | -8.42 | -5.53 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 21.79 | 11.14 | 10.89 | 7.55 |
Depreciation | -6.43 | -4.39 | -3.05 | -2.85 |
Tax paid | -6.38 | -2.7 | -3.34 | -2.87 |
Working capital | 3.88 | 11.55 | 1.1 | 6.11 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 88.56 | -16.02 | 20.7 | 43.54 |
Op profit growth | 107.32 | -7.37 | 32.62 | 34.55 |
EBIT growth | 78.98 | 4.05 | 34.65 | 26.66 |
Net profit growth | 82.82 | 11.71 | 61.4 | 35.96 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 370.2 | 307.17 | 251.03 | 456.19 | 262.01 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 370.2 | 307.17 | 251.03 | 456.19 | 262.01 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.92 | 1.83 | 2.94 | 3.51 | 1.59 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,694.7 | 93.17 | 4,06,615.3 | 705.44 | 0.94 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,024.95 | 63.62 | 1,59,943.49 | 696 | 0.5 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,939.65 | 62.47 | 1,33,335.66 | 597 | 0.15 | 2,707 | 249.82 |
Cipla Ltd CIPLA | 1,330.8 | 23.46 | 1,07,499.45 | 616.88 | 1.2 | 4,256.93 | 411.55 |
Dr Reddys Laboratories Ltd DRREDDY | 1,241.15 | 22.33 | 1,03,590.15 | 90.6 | 0.64 | 4,266.4 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director & MD
Ramesh Arora
E D & Wholetime Director
Ajay Arora
Executive Director / Whole Time Director / CFO
Aditya Arora
E D & Wholetime Director
Geeta Arora
E D & Wholetime Director
Anju Arora
Independent Non Exe. Director
Kartik Kapur
Independent Non Exe. Director
Prashanth Vellanki
Independent Non Exe. Director
Vinod Kumar Sharma
Company Sec. & Compli. Officer
Gurpreet Kaur
Independent Non Exe. Director
Bhavesh Mahajan
Independent Non Exe. Director
Preet Mohinder S Bedi
Village Nagkalan,
Majitha Road,
Punjab - 143601
Tel: 91-183-2774321-25
Website: http://www.kwalitypharma.com
Email: cs@kwalitypharma.com
E-2/3 Ansa Indl Est,
Saki Vihar Road, Sakinaka Andheri(E),
Mumbai - 400072
Tel: 91-22-40430200/28470
Website: www.bigshareonline.com
Email: investor@bigshareonline.com
Summary
Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinn...
Read More
Reports by Kwality Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.